News Sentiment

RNAC sentiment intelligence

Cartesian Therapeutics Inc. news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 53 Balanced news tone 50 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 9.46 Week of 10 Jul 2026
Weighted tone 53/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

80/100 classification confidence.

Company focus 42

directly relevant articles

Source quality 2

high-authority source matches

Trend context Trend active

-10.7% over one week, -0.5% over four weeks, trend active, and below fair value.

Latest direct headline Neutral

Enterprise value to EBITDA forward of Cartesian Therapeutics, Inc. – NASDAQ:RNAC

Market Reaction

Price moving ahead of tone

62/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 80/100 classification
One-week reaction -10.7% Price reacting lower
Trend fit Trend active -0.5% over four weeks
Fair value -44.1% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 11
Neutral 35
Negative 4

Relevance

Why the article matched

Direct first
Direct company coverage 42
Industry context 8
Sector context 0

Sources

Coverage mix

Publishers
TradingView 9
Market source 7
Stock Titan 5
simplywall.st 4
24/7 Wall St. 3
TradingKey 3
GlobeNewswire 3
MSN 2

Event Lens

What the news is about

Classified themes
Market update 28
Earnings 13
Analyst action 3
Balance sheet 3
Deals and strategy 2
Macro sensitivity 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-50 of 50